Average Co-Inventor Count = 3.97
ph-index = 21
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Onyx Therapeutics, Inc. (17 from 50 patents)
2. Pharmacyclics, Inc. (14 from 193 patents)
3. Proteolix, Inc. (3 from 5 patents)
4. Other (2 from 832,843 patents)
5. Eli Lilly and Company (1 from 4,446 patents)
6. Portola Pharmaceuticals, Inc. (1 from 70 patents)
7. Onyx Technologies, Inc. (1 from 1 patent)
8. Janssen Pharmaceutica Nv (2,078 patents)
39 patents:
1. 10961251 - Crystalline forms of a Bruton's tyrosine kinase inhibitor
2. 10752634 - Crystalline forms of a brutons tyrosine kinase inhibitor
3. 10294232 - Crystalline forms of a Bruton's tyrosine kinase inhibitor
4. 10294231 - Crystalline forms of a Bruton's tyrosine kinase inhibitor
5. 10266540 - Crystalline forms of a Bruton's tyrosine kinase inhibitor
6. 10125140 - Crystalline forms of a bruton's tyrosine kinase inhibitor
7. 10106548 - Crystalline forms of a Bruton's tyrosine kinase inhibitor
8. 10065968 - Crystalline forms of a bruton's tyrosine kinase inhibitor
9. 9828383 - Crystalline forms of a bruton's tyrosine kinase inhibitor
10. 9725455 - Crystalline forms of a bruton's tyrosine kinase inhibitor
11. 9713617 - Crystalline forms of a Bruton's tyrosine kinase inhibitor
12. 9657058 - Compounds for enzyme inhibition
13. 9540382 - Crystalline forms of a Bruton's tyrosine kinase inhibitor
14. 9296753 - Crystalline forms of a Bruton's tyrosine kinase inhibitor
15. 9012463 - Inhibitors of bruton's tyrosine kinase